Clinical Trials Browser

Completed × OTHER × lorlatinib × Clear all

NCT03107988 2025-09-15

NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)

Phase 1 Completed

65 enrolled 38 charts

Neuroblastoma

NCT04111705 2025-04-01

ORAKLE

Phase 2 Completed

Non Small Cell Lung Cancer Metastatic

NCT05167500 2023-03-30

LORLAPULM

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasm Metastasis